Elucidating structural and molecular mechanisms of β-arrestin-biased agonism at GPCRs via MS-based proteomics
Keywords: آگونیست انگیخته; 7TMR; GPCR; Arrestin; β-Arrestin; Biased agonism; Biased agonist; Mass spectrometry; Proteomics; Pharmacology; Drug discovery;